Manuel Torres-Diz
10PUBLICATIONS
46CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Feb 06, 2026
The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy target.Zhiwei Ang, Annette Castro, Luca Paruzzo
|Aug 02, 2024
An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia.Manuel Torres-Diz, Clara Reglero, Catherine D Falkenstein
|Aug 02, 2024
An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia.Manuel Torres-Diz, Clara Reglero, Catherine D Falkenstein
|Sep 08, 2023
Alternative splicing of its 5'-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies.Zhiwei Ang, Luca Paruzzo, Katharina E Hayer
|Aug 30, 2023
Alternative splicing of its 5'-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies.Zhiwei Ang, Luca Paruzzo, Katharina E Hayer
|Jan 11, 2022
Modulation of CD22 Protein Expression in Childhood Leukemia by Pervasive Splicing Aberrations: Implications for CD22-Directed Immunotherapies.Sisi Zheng, Elisabeth Gillespie, Ammar S Naqvi
Pageof 2
Frequent Collaborators
8 joint publications
Katharina Hayer
8 joint publications
Andrei Thomas-Tikhonenko
5 joint publications
Zhiwei Ang
5 joint publications
Priyanka Sehgal
5 joint publications
Yoseph Barash
4 joint publications
Sarah K Tasian
4 joint publications
Marco Ruella
3 joint publications
Luca Paruzzo
2 joint publications
Scarlett Y Yang
2 joint publications
Paul M Lieberman
